Senti Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 48
- Market Cap
- $12.5M
- Introduction
Senti Biosciences, Inc. It was incorporated in Delaware on March 1, 2021. The company aims to design genetic circuits to improve the intelligence of cells and gene therapy to improve its effectiveness, accuracy and persistence in the treatment of a wide range of diseases that cannot be solved by traditional drugs. The company's synthetic biology platform use...
SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Senti Biosciences
- Target Recruit Count
- 21
- Registration Number
- NCT06325748
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸Colorado Blood Cancer Institute, Denver, Colorado, United States
🇺🇸TriStar Bone Marrow Transplant, Nashville, Tennessee, United States
© Copyright 2024. All Rights Reserved by MedPath